KOR
ENG
About us
Our Company
History
Members
Our Science
ADC Technology
Pipelines
Publications
IR/PR
Notice
Press Release
Contact us
Contact Us
KOR
ENG
IR/PR
Press Release
Notice
Press Release
Press Release
(2025-09-19) AimedBio Receives Approval for KOSDAQ Listing
2025.10.14
(2025-08-29) 3rd SMC X AimedBio ADC Conference Attracts 538 Industry and Academia Experts
2025.10.14
(2025-08-25) AimedBio Named to Forbes Asia 100 to Watch 2025
2025.10.14
(2025-06-24) Aimed Bio Clears Technical Hurdle for KOSDAQ Listing as ADC Pipeline Gains Momentum
2025.10.14
(2025-06-19) AMB304, selected as a KDDF project
2025.10.14
(2025-06-09) AMB303, Research Collaboration and License Option Agreement signed with SK Plasma
2025.10.14
(2025-06-02) AimedBio secures 38 million USD in a pre-IPO funding round
2025.10.14
(2025-04-17) AimedBio Receives IND Approval for AMB302 from Korea’s Ministry of Food and Drug Safety (MFDS)
2025.10.14
(2025-02-14) AMB302 Granted Orphan Drug Designation (ODD) by the U.S. FDA
2025.10.14
(2025-01-14) AimedBio Signs Exclusive Global Licensing Agreement with Biohaven for FGFR3 ADC, AMB302
2025.10.14
1
2
3
Contact Us >>